Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 84

Sort by

Sort Order Select

Journal Articles

Dietary iron restriction improves markers of disease severity in murine sickle cell anemia

Nermi L. Parrow, Pierre-Christian Violet, Nisha Ajit George, Faris Ali, Shivam Bhanvadia, Ryan Wong, John F. Tisdale, Courtney Fitzhugh, Mark Levine, Swee Lay Thein, Robert E. Fleming

Blood (2021) 137 (11): 1553–1555.

https://doi.org/10.1182/blood.2020006919

Published: 2021

Includes: Supplemental data

Journal Articles

Sensing of Liver Iron Content Requires Cell-Cell Communication between Hepatocytes and Liver Sinusoidal Endothelial Cells

Silvia Colucci, Sandro Altamura, PhD, Matthias Hentze, Prof., Martina U. Muckenthaler, PhD

Blood (2019) 134 (Supplement_1): 432.

https://doi.org/10.1182/blood-2019-125586

Published: 2019

Journal Articles

Iron Restriction Improves Markers of Disease Severity in the Townes Mouse Model of Sickle Cell Anemia

Nermi Parrow, PhD, Pierre-Christian Violet, PhD, Nisha George, PhD, Faris Ali, Shivam Bhanvadia, Mark Levine, MD, Robert E Fleming, MD

Blood (2019) 134 (Supplement_1): 2261.

https://doi.org/10.1182/blood-2019-130732

Published: 2019

Journal Articles

Effect of Oral Iron Treatment in Tmprss6 Knock-out Mouse Model

Elisa Brilli, PhD, Michela Asperti, PhD, Annalisa Castagna, B.S., PhD, Claudio Cerchione, MD PhD, Domenico Girelli, MD, PhD, Maura Poli, PhD, Germano Tarantino

Blood (2019) 134 (Supplement_1): 2235.

https://doi.org/10.1182/blood-2019-122416

Published: 2019

Journal Articles

Iron Deficiency Anemia Caused By Malabsorption from Proton Pump Inhibition

Michael Boxer, MD

Blood (2019) 134 (Supplement_1): 962.

https://doi.org/10.1182/blood-2019-122154

Published: 2019

Journal Articles

Regulation of Iron Homeostasis By PTG-300 Improves Disease Parameters in Mouse Models for Beta-Thalassemia and Hereditary Hemochromatosis

Roopa Taranath, PhD, Gregory Bourne, PhD, Li Zhao, MD PhD, Brian Frederick, MS, Chelsea King, BA, David Liu, PhD

Blood (2019) 134 (Supplement_1): 3540.

https://doi.org/10.1182/blood-2019-129309

Published: 2019

Journal Articles

Proton Pump Inhibition for Secondary Hemochromatosis in Hereditary Anemia, a Phase III Placebo Controlled Randomized Cross-over Trial in Progress

Annelies J. Van Vuren, MD, Bart J. Biemond, MD PhD, Jean-Louis Kerkhoffs, MD PhD, Saskia E.M. Schols, MD PhD, A. W. Rijneveld, MD PhD, Erfan Nur, MD PhD, Richard van Wijk, PhD, Tim Leiner, MD PhD, Joannes J.M. Marx, Emeritus Professor, Eduard J. van Beers, MD PhD

Blood (2019) 134 (Supplement_1): 960.

https://doi.org/10.1182/blood-2019-124059

Published: 2019

Journal Articles

Iron metabolism under conditions of ineffective erythropoiesis in β-thalassemia

Stefano Rivella

Blood (2019) 133 (1): 51–58.

https://doi.org/10.1182/blood-2018-07-815928

Published: 2019

Journal Articles

Kinetics of Iron Depletion in Hereditary Hemochromatosis

Cristina Sanz, MD PhD, Anna Garcia-Carulla, Arturo Pereira, MD PhD

Blood (2018) 132 (Supplement 1): 3630.

https://doi.org/10.1182/blood-2018-99-110457

Published: 2018

Journal Articles

Transmembrane Protease, Serine 6 (TMPRSS6) Antisense Oligonucleotide (IONIS-TMPRSS6-L RX ) Reduces Plasma Iron Levels of Healthy Volunteers in a Phase 1 Clinical Study

Michael McCaleb, PhD, Jason Lickliter, MBBS, PhD, Andrew Dibble, PhD, Eugene Schneider, MD, Mariam Aghajan, Shuling Guo, Steve Hughes, MD MBA, Richard S Geary, PhD, Brett P. Monia, PhD

Blood (2018) 132 (Supplement 1): 3634.

https://doi.org/10.1182/blood-2018-99-115339

Published: 2018

Journal Articles

NCOA4 Mediates Mobilization of Hepatic Iron Stores after Blood Loss

Xiuqi Li, MS, Larisa Lozovatsky, MS, Dong Liu, PhD, Nadia Ayala-Lopez, PhD MT(ASCP), Karin E. Finberg, MD PhD

Blood (2018) 132 (Supplement 1): 1046.

https://doi.org/10.1182/blood-2018-99-119469

Published: 2018

Journal Articles

Effects of Sucrosomial ® iron in Pre-Clinical and Clinical Conditions of Inflammation

Elisa Brilli, PhD, Maura Poli, PhD, Asperti Michela, Giulio Giordano, Elena Pera, PhDMSc,MPhil, Francesco Equitani, MD, Germano Tarantino

Blood (2017) 130 (Supplement 1): 942.

https://doi.org/10.1182/blood.V130.Suppl_1.942.942

Published: 2017

Journal Articles

The Macrophage Nuclear Receptor Coactivator 4 Counteracts Iron-Deficiency Anemia

Antonella Nai, PhD, Maria Rosa Lidonnici, Irene Artuso, MSc, Giorgia Federico, PhD, Giacomo Mandelli, Giuliana Ferrari, PhD, Clara Camaschella, MD, Francesca Carlomagno, MD, Laura Silvestri, PhD

Blood (2017) 130 (Supplement 1): 224.

https://doi.org/10.1182/blood.V130.Suppl_1.224.224

Published: 2017

Journal Articles

Iron Binding to Specific Lobes of Transferrin Differentially Affects Erythropoiesis and Hepcidin Signaling

Nermi Parrow, PhD, Amaliris Gonzalez, PhD, Yihang Li, PhD, Princy Prasad, Luke Mammen, Faris Ali, Edvinas Vaicikauskas, Maria Feola, PhD, Yelena Ginzburg, MD, Stefano Rivella, PhD, Robert E Fleming, MD

Blood (2017) 130 (Supplement 1): 173.

https://doi.org/10.1182/blood.V130.Suppl_1.173.173

Published: 2017

Journal Articles

A Novel Dual Monoclonal Sandwich ELISA for Human Erythroferrone

Huiling Han, MD, Keith Westerman, BS, Vaughn Ostland, PhD, Patrick Gutschow, MS, Gordana Olbina, PhD, Jacqueline da Silva Guimarães, PhD, Juçara Gastaldi Cominal, M.Sc, Ana Maria de Souza, PhD, Ana Cristina Silva Pinto, MD, Stefano Rivella, PhD, Yelena Ginzburg, MD, Mark D. Fleming, MD DPhil, Mark Westerman, PhD

Blood (2016) 128 (22): 1272.

https://doi.org/10.1182/blood.V128.22.1272.1272

Published: 2016

Journal Articles

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of an Anti-Ferroportin Antibody in Patients with Anemia Due to Chronic Renal Failure

Philip Barrington, BM, MFPM, Matthew J Sheetz, MD PhD, Sophie Callies, PhD PharmD, D G Waters, Paul H Berg, MS, Donna Pappas, Thomas C Marbury, MD, Brian S Decker, MD PharmD, Jolene Kay Berg, MD

Blood (2016) 128 (22): 1280.

https://doi.org/10.1182/blood.V128.22.1280.1280

Published: 2016

Journal Articles

Heme-Regulated eIF2α Kinase Coordinates Translational Repression of eIF2αP and mTORC1 Signaling during Iron Deficiency to Mitigate Ineffective Erythropoiesis

Shuping Zhang, PhD, Alejandra Macias-Garcia, PhD, Jason Velazquez, BS, Jane-Jane Chen, PhD

Blood (2016) 128 (22): 1037.

https://doi.org/10.1182/blood.V128.22.1037.1037

Published: 2016

Journal Articles

Developing a Galnac-Conjugated TMPRSS6 Antisense Therapy for the Treatment of β-Thalassemia

Mariam Aghajan, PhD, Carla Casu, PhD, Vania lo Presti, Sheri Booten, Brett P. Monia, PhD, Stefano Rivella, PhD, Shuling Guo, PhD

Blood (2016) 128 (22): 1013.

https://doi.org/10.1182/blood.V128.22.1013.1013

Published: 2016

Journal Articles

Geophagia: A Scientific Approach to a Historical Practice to Sustainably Treat Endemic Iron Deficiency in a Rural Community in Nepal

Binay Lama, Rachael Jones, MSc, Nicola Barlow, MChem, DPhil, MSc, FRCPath, Russell D Keenan, MB ChB, PhD FRCP, FRCPath

Blood (2016) 128 (22): 2346.

https://doi.org/10.1182/blood.V128.22.2346.2346

Published: 2016

Journal Articles

Low-Iron Diet and Chelation Therapy Rescue Severe Atherosclerosis Associated with High Circulating Iron Levels

Francesca Vinchi, PhD, Andreas Simmelbauer, Master student, Sandro Altamura, PhD, Sebastian Spaich, Richard Sparla, Bruno Galy, PhD, Matthias W. Hentze, MD, Martina U. Muckenthaler, PhD

Blood (2016) 128 (22): 199.

https://doi.org/10.1182/blood.V128.22.199.199

Published: 2016

NARROW

Dietary iron restriction improves markers of disease severity in murine sickle cell anemia

Sensing of Liver Iron Content Requires Cell-Cell Communication between Hepatocytes and Liver Sinusoidal Endothelial Cells

Iron Restriction Improves Markers of Disease Severity in the Townes Mouse Model of Sickle Cell Anemia

Effect of Oral Iron Treatment in Tmprss6 Knock-out Mouse Model

Iron Deficiency Anemia Caused By Malabsorption from Proton Pump Inhibition

Regulation of Iron Homeostasis By PTG-300 Improves Disease Parameters in Mouse Models for Beta-Thalassemia and Hereditary Hemochromatosis

Proton Pump Inhibition for Secondary Hemochromatosis in Hereditary Anemia, a Phase III Placebo Controlled Randomized Cross-over Trial in Progress

Iron metabolism under conditions of ineffective erythropoiesis in β-thalassemia

Kinetics of Iron Depletion in Hereditary Hemochromatosis

Transmembrane Protease, Serine 6 (TMPRSS6) Antisense Oligonucleotide (IONIS-TMPRSS6-L RX ) Reduces Plasma Iron Levels of Healthy Volunteers in a Phase 1 Clinical Study

NCOA4 Mediates Mobilization of Hepatic Iron Stores after Blood Loss

Effects of Sucrosomial ® iron in Pre-Clinical and Clinical Conditions of Inflammation

The Macrophage Nuclear Receptor Coactivator 4 Counteracts Iron-Deficiency Anemia

Iron Binding to Specific Lobes of Transferrin Differentially Affects Erythropoiesis and Hepcidin Signaling

A Novel Dual Monoclonal Sandwich ELISA for Human Erythroferrone

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of an Anti-Ferroportin Antibody in Patients with Anemia Due to Chronic Renal Failure

Heme-Regulated eIF2α Kinase Coordinates Translational Repression of eIF2αP and mTORC1 Signaling during Iron Deficiency to Mitigate Ineffective Erythropoiesis

Developing a Galnac-Conjugated TMPRSS6 Antisense Therapy for the Treatment of β-Thalassemia

Geophagia: A Scientific Approach to a Historical Practice to Sustainably Treat Endemic Iron Deficiency in a Rural Community in Nepal

Low-Iron Diet and Chelation Therapy Rescue Severe Atherosclerosis Associated with High Circulating Iron Levels

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only